The Netherlands Competition Authority establishes the illegal character of the resale prohibition imposed by a pharmaceutical company on hospitals (AstraZeneca)

NMA: PROHIBITION BY ASTRAZENECA ON SALES TO THIRD PARTIES CONTRAVENES COMPETITION ACT* The prohibition against supplying parties outside the premises of hospitals, imposed on hospitals and pharmacies by AstraZeneca, contravenes the Competition Act. NMa made this ruling in a decision relating to the medicine

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Netherlands Competition Authority, The Netherlands Competition Authority establishes the illegal character of the resale prohibition imposed by a pharmaceutical company on hospitals (AstraZeneca), 9 July 2002, e-Competitions Bulletin July 2002, Art. N° 65771

Visites 123

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues